Literature DB >> 2316628

Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters.

Y Takiyama1, H Egami, P M Pour.   

Abstract

Our previous studies have shown that pancreatic cancer induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine (BOP) shows remarkable similarities with the human disease in morphologic and biologic characteristics. Moreover, both human and hamster pancreatic cancer share expression of some tumor-associated antigens, such as those with blood group specificities, including A, B, H, Leb, Lex, and Ley. By examining other antigens commonly expressed in human pancreatic cancer, we have found that monoclonal antibodies CO17-1A (recognizing 17-1A antigen), OC 125 (recognizing CA 125 antigen), B72.3 (recognizing TAG-72 and DU-PAN-2 react with induced pancreatic cancer in a pattern similar to that seen in human pancreatic cancer. Remarkably, although the epitopes of the antigens recognized by these three antibodies are different, many tumor cells were reactive with all these antibodies. However, in contrast to the human cancer, none of these antigens were expressed in the normal hamster pancreatic tissue, except for 17-1A. However, all of these antigens were expressed in some hamster tissues showing the same cellular localization as pancreatic cancer cells and corresponded, to a great extent, with findings in human tissue. Expression of these antigens was diminished in vitro (cell culture) but was regained in vivo (homologous transplantation). The results emphasize the usefulness of this experimental model for studying some aspects of tissue antigenicity, particularly as it relates to pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316628      PMCID: PMC1877476     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Pancreatic neoplasms in an animal model: morphological, biological, and comparative studies.

Authors:  P Pour; U Mohr; A Cardesa; J Althoff; F W Krüger
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases.

Authors:  Y Takiyama; M A Tempero; H Takasaki; M Onda; R Tsuchiya; M Büchler; M Ness; D Colcher; J Schlom; P M Pour
Journal:  Hum Pathol       Date:  1989-09       Impact factor: 3.466

3.  Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue.

Authors:  H Takasaki; M A Tempero; E Uchida; M Büchler; M J Ness; D A Burnett; R S Metzgar; D Colcher; J Schlom; P M Pour
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

4.  Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens.

Authors:  H Egami; Y Takiyama; M Cano; W H Houser; P M Pour
Journal:  Carcinogenesis       Date:  1989-05       Impact factor: 4.944

5.  Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.

Authors:  P M Pour; M M Tempero; H Takasaki; E Uchida; Y Takiyama; D A Burnett; Z Steplewski
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

6.  Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.

Authors:  H Takasaki; E Uchida; M A Tempero; D A Burnett; R S Metzgar; P M Pour
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

7.  Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients.

Authors:  D Colcher; J M Esteban; J A Carrasquillo; P Sugarbaker; J C Reynolds; G Bryant; S M Larson; J Schlom
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

8.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.

Authors:  T Kjeldsen; H Clausen; S Hirohashi; T Ogawa; H Iijima; S Hakomori
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

9.  Co-expression of human cancer-associated epitopes on mucin molecules.

Authors:  M S Lan; R C Bast; M I Colnaghi; R C Knapp; D Colcher; J Schlom; R S Metzgar
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

10.  A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine.

Authors:  P Pour; J Althoff; F W Krüger; U Mohr
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

View more
  9 in total

Review 1.  The role of Langerhans islets in exocrine pancreatic cancer.

Authors:  P M Pour
Journal:  Int J Pancreatol       Date:  1995-06

2.  Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans.

Authors:  P M Pour; L Weide; G Liu; K Kazakoff; M Scheetz; I Toshkov; Y Ikematsu; M A Fienhold; W Sanger
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 3.  The link between exocrine pancreatic cancer and the endocrine pancreas.

Authors:  P M Pour; B Schmied
Journal:  Int J Pancreatol       Date:  1999-04

4.  Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters.

Authors:  H Egami; T Tomioka; M Tempero; D Kay; P M Pour
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

5.  Establishment and characterization of a new hamster pancreatic cancer cell line: the biological activity and the binding characteristics of EGF or TGF-alpha.

Authors:  Y Morita; T Moriai; Y Takiyama; I Makino
Journal:  Int J Pancreatol       Date:  1998-02

6.  Localization of galectin-3 in normal and diseased pancreatic tissue.

Authors:  C Schaffert; P M Pour; W G Chaney
Journal:  Int J Pancreatol       Date:  1998-02

7.  Immunohistochemical localization of group II phospholipase A2 in human pancreatic carcinomas.

Authors:  H Kiyohara; H Egami; H Kako; Y Shibata; K Murata; S Ohshima; K Sei; S Suko; R Kurano; M Ogawa
Journal:  Int J Pancreatol       Date:  1993-02

8.  Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).

Authors:  P Mikvy; H Messman; A J MacRobert; M Pauer; V R Sams; C L Davies; J C Stewart; S G Bown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.

Authors:  J Regula; B Ravi; J Bedwell; A J MacRobert; S G Bown
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.